Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v14-EN | Version v1-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2020-12-16 | 2020-12-01 |
| Drug Identification Number | 02231593 | 02231593 |
| Brand name | DURATOCIN | DURATOCIN |
| Common or Proper name | Carbetocin Injection (ampoules) | Carbetocin Injection (ampoules) |
| Company Name | FERRING INC | FERRING INC |
| Ingredients | CARBETOCIN | CARBETOCIN |
| Strength(s) | 100MCG | 100MCG |
| Dosage form(s) | LIQUID SOLUTION | LIQUID SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | 1 mL ampoule - 100 mcg / mL | 1 mL ampoule - 100 mcg / mL |
| ATC code | H01BB | H01BB |
| ATC description | POSTERIOR PITUITARY LOBE HORMONES | POSTERIOR PITUITARY LOBE HORMONES |
| Reason for shortage | Delay in shipping of the drug. | Delay in shipping of the drug. |
| Anticipated start date | ||
| Actual start date | 2020-10-20 | 2020-10-20 |
| Estimated end date | 2020-12-15 | 2020-12-07 |
| Actual end date | 2020-12-15 | |
| Shortage status | Resolved | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Substitute with DURATOCIN 100 mcg room temperature vials. 1 mL vial, 100 mcg / mL; UPC 779170191008; DIN 02496526. Store at: 15°C to 30°C. Available now and in stock; DURATOCIN (carbetocin injection) room temperature vials are indicated for the prevention of postpartum haemorrhage by controlling uterine atony. Duratocin room temperature vials have the same efficacy and safety features as ampoules with expanded indication for vaginal deliveries. | Substitute with DURATOCIN 100 mcg room temperature vials 1 mL vial, 100 mcg / mL UPC 779170191008, DIN02496526 Store at: 15°C to 30°C Available now and in stock; DURATOCIN (carbetocin injection) room temperature vials are indicated for the prevention of postpartum haemorrhage by controlling uterine atony. Duratocin room temperature vials have the same efficacy and safety features as ampoules with expanded indication for vaginal deliveries. |
| Health Canada comments |